title: Epidemiology of human T-cell lymphotropic virus type 1 infection in blood donors, Israel.
abstract: The prevalence of infection with human T-cell lymphotropic virus type 1 (HTLV-1) in blood donors from Israel is 1 infection/100,000 persons. In donors originating from Eastern Europe, the Middle East, and Latin America, prevalences are 7.7, 14.6, and 20.4, respectively. HTLV-1 prevalence may be high outside areas where HTLV-1 previously was known to be endemic.
authors.affiliation: Sheba Medical Center, Tel Hashomer, Israel. sshmuel@netvision.net.il
authors.forename: Shmuel
authors.initials: S
authors.lastname: Stienlauf
authors.forename: Vered
authors.initials: V
authors.lastname: Yahalom
authors.forename: Eli
authors.initials: E
authors.lastname: Schwartz
authors.forename: Eilat
authors.initials: E
authors.lastname: Shinar
authors.forename: Gad
authors.initials: G
authors.lastname: Segal
authors.forename: Yechezkel
authors.initials: Y
authors.lastname: Sidi
mesh_terms: D000465:Algorithms; D001782:Blood Donors / Q000706:statistics & numerical data*; D004641:Emigration and Immigration / Q000706:statistics & numerical data; D005260:Female; D005843:Geography; D015481:HTLV-I Antibodies / Q000097:blood; D015490:HTLV-I Infections / Q000453:epidemiology* / Q000276:immunology; D015482:HTLV-II Antibodies / Q000097:blood; D006801:Humans; D007557:Israel / Q000453:epidemiology; D008297:Male; D008403:Mass Screening / Q000592:standards; D015995:Prevalence
chemical_list: D015481:HTLV-I Antibodies; D015482:HTLV-II Antibodies